This exchange-traded fund (ETF) invests in companies from around the world that are expected to derive revenue from technological innovations in the genomic healthcare sector. Income is reinvested into the fund.
This exchange-traded fund (ETF) invests in companies from around the world that are expected to derive revenue from technological innovations in the genomic healthcare sector. Income is reinvested into the fund.